Coherus Oncology, Inc. Shareholders' Equity
Coherus Oncology, Inc. (CHRS) had Shareholders' Equity of $60.84 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $60.84M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $78.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $61.01M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $87.77M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $60.84M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $78.62M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $61.01M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $87.77M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $119.83M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | -$183.47M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | -$131.99M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | -$87.97M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$84.11M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | -$81.84M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | -$193.43M 10-K · filed 2026-03-09 | |
| 2023-09-30 | -$133.60M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -$174.76M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | -$196.51M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | -$137.42M 8-K · filed 2025-11-13 | |
| 2022-09-30 | -$97.13M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | -$22.63M 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $12.56M 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $97.73M 10-K · filed 2025-03-17 | |
| 2021-09-30 | $130.76M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $156.22M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $127.67M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $280.97M 10-K · filed 2024-03-15 | |
| 2020-09-30 | $255.73M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $213.38M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $157.28M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $105.21M 10-K · filed 2023-03-06 | |
| 2018-12-31 | -$38.59M 10-K · filed 2022-02-23 | |
| 2018-09-30 | $12.39M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $63.17M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$1.79M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $30.54M 10-K · filed 2021-02-25 | $31.82M 10-K · filed 2018-03-08 |
| 2017-09-30 | $56.20M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $32.14M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $78.18M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $20.53M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $32.87M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$60.89M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$66.01M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$6.21M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $40.57M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $96.75M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $38.15M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $66.80M 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$151.83M 10-Q · filed 2014-12-15 | |
| 2013-12-31 | -$97.08M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |